Hodaka Yamada
Omiya, 3308503, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Real-world effectiveness and safety of imeglimin in Japanese patients with type 2 diabetes: a retrospective observational study.
Journal: Diabetology international
Published: September 17, 2025
The importance of daily life activities in managing obesity in patients with type 2 diabetes mellitus: a study using physical activity records.
Journal: Diabetology international
Published: May 12, 2025
Soluble αKlotho concentration in the inferior vena cava of patients with primary aldosteronism.
Journal: Nefrologia
Published: December 22, 2023
Retrospective Study of IDegLira, a New Fixed-Ratio Combination, in Japanese Patients With Type 2 Diabetes Mellitus: Analysis of Background Factors Affecting Effectiveness After 6 Months of Treatment.
Journal: Journal of clinical medicine research
Published: July 18, 2023
Retrospective Analysis of the Effectiveness of Oral Semaglutide in Type 2 Diabetes Mellitus and Its Effect on Cardiometabolic Parameters in Japanese Clinical Settings.
Journal: Journal of cardiovascular development and disease
Published: March 18, 2023
Correction: Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: January 10, 2023
Teneligliptin, a DPP-4 Inhibitor, Improves Vascular Endothelial Function via Divergent Actions Including Changes in Circulating Endothelial Progenitor Cells.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: January 09, 2023
Effectiveness and Safety of Once-Weekly Semaglutide in Japanese Patients with Type 2 Diabetes in Treatment Intensification: A Retrospective Observational Single-Center Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: July 04, 2022
Hypereosinophilia is a predictive biomarker of immune checkpoint inhibitor-induced hypopituitarism in patients with renal cell carcinoma.
Journal: BMC endocrine disorders
Published: October 27, 2021
Real-World Incidence of Immune-Related Adverse Events Associated with Nivolumab Plus Ipilimumab in Patients with Advanced Renal Cell Carcinoma: A Retrospective Observational Study.
Journal: Journal of clinical medicine
Published: August 24, 2021
Pseudo Intestinal Obstruction Caused by Malignant Paraganglioma.
Journal: Internal medicine (Tokyo, Japan)
Published: May 24, 2021
Last Updated: 09/26/2026